Barclays analyst Luke Sergott raised the firm’s price target on Agilent to $135 from $125 and keeps an Underweight rating on the shares. The company reported a solid quarter “with nothing to pick at,” the analyst tells investors in a research note. The firm says management is starting to see some “greenshoots” in demand but the question is when will we see Instrument demand pick up enough to call an inflection with the upgrade cycle.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on A:
- A Earnings: Agilent Rises amid Solid Q3 Results
- Agilent narrows FY24 EPS view to $5.21-$5.25 from $5.15-$5.25, consensus $5.20
- Agilent sees Q4 adjusted EPS $1.38-$1.42, consensus $1.44
- Agilent reports Q3 adjusted EPS $1.32, consensus $1.26
- Agilent options imply 4.5% move in share price post-earnings